Stronger demand for cancer tests and genetic screenings helped drive the diagnostics company's quarterly outperformance and prompted a higher full-year forecast.
Labcorp lifted its full-year earnings outlook after beating expectations in the second quarter, with demand for cancer tests and genetic screenings cited as the main drivers. The update points to continued strength in diagnostics, where higher volumes in specialized testing can support earnings and signal resilient healthcare demand.